Smartlab Europe

Press Releases

Pharmaspectra Group Limited Partners with IBM Watson Health to Help Life Sciences Companies with Stakeholder Management

Pharmaspectra, the world’s largest collection of medical science, announced it has entered into a partnership with IBM Watson Health. Through the partnership agreement, IBM Watson Health is withdrawing IBM Stakeholder Manager® from its portfolio and offering a transition path for...

CPhI Middle East & Africa to take place in September 2021 under the patronage of Saudi Arabia’s Ministry of Health

Informa Markets, the organisers of the leading regional pharmaceutical event CPhI Middle East & Africa, (CPhI MEA), has announced the 2020 edition of the show will be held alongside the Global Health Exhibition (GHE) in Riyadh, Saudi Arabia on...

Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen’s COVID-19 Vaccine Candidate

Johnson & Johnson announced the launch of its large-scale, pivotal, multi-country Phase 3 trial (ENSEMBLE) for its COVID-19 vaccine candidate, JNJ-78436735, being developed by its Janssen Pharmaceutical Companies. The initiation of the ENSEMBLE trial follows positive interim results from...

Sanofi and GSK sign agreements with the Government of Canada to supply up to 72 million doses of adjuvanted COVID-19 vaccine

Sanofi and GSK have signed agreements with the Government of Canada for the supply of up to 72 million doses of an adjuvanted COVID-19 vaccine, beginning in 2021. “Today’s announcement showcases our unwavering commitment to develop a COVID-19 vaccine that...

Sun Pharma Announces the Launch of ILUMYA for Treatment of Plaque Psoriasis in Japan

Sun Pharmaceutical Industries Limited and includesits subsidiaries and/or associate companies) announced that its wholly-owned Japanese subsidiary has launched ILUMYA® Subcutaneous Injection 100 mg Syringe (Nonproprietary name: tildrakizumab(genetical recombination), “ILUMYA”) in Japan for the treatment of plaque psoriasis in adult...

T-knife and Catalent Sign Technology Transfer and Manufacturing Agreement for Autologous T-Cell Receptor-Based Cell Therapy

T-knife GmbH, a next-generation adoptive T-cell company using its proprietary humanized T-cell receptor (HuTCR) mouse platform to treat solid tumors, and Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and...

Europital launches as a science-driven full service CRO

Expanded CRO services to support biotechs and mid-sized pharma companies across trials in more than 40 countries Europital – a globally-focused full service CRO serving small and mid-tier innovators – announces a significant expansion as it launches new capabilities across...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »